4.3 Editorial Material

AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome

Guillaume Canaud et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Biochemistry & Molecular Biology

AKT2 is essential to maintain podocyte viability and function during chronic kidney disease

Guillaume Canaud et al.

NATURE MEDICINE (2013)

Review Medicine, General & Internal

The Pathogenesis of the Antiphospholipid Syndrome

Bill Giannakopoulos et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Multidisciplinary Sciences

Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity

Dudley W. Lamming et al.

SCIENCE (2012)

Review Rheumatology

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Pier Luigi Meroni et al.

NATURE REVIEWS RHEUMATOLOGY (2011)

Review Biochemistry & Molecular Biology

AKT/PKB signaling: Navigating downstream

Brendan D. Manning et al.

Article Biochemistry & Molecular Biology

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

DD Sarbassov et al.

MOLECULAR CELL (2006)

Article Medicine, General & Internal

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

HJ Eisen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Medicine, General & Internal

Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.

PC Grimm et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)